Total Payments
$12,220
2024 Payments
$55.07
Companies
8
Transactions
32
Medicare Patients
1,366
Medicare Billing
$246,079
Payment Breakdown by Category
Other$10,060 (82.3%)
Travel$1,368 (11.2%)
Food & Beverage$670.72 (5.5%)
Education$56.94 (0.5%)
Consulting$45.00 (0.4%)
Gifts$19.40 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $10,060 | 3 | 82.3% |
| Travel and Lodging | $1,368 | 4 | 11.2% |
| Food and Beverage | $670.72 | 20 | 5.5% |
| Education | $56.94 | 3 | 0.5% |
| Consulting Fee | $45.00 | 1 | 0.4% |
| Gift | $19.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $8,146 | 12 | $0 (2021) |
| Horizon Pharma plc | $3,796 | 5 | $0 (2018) |
| MERZ NORTH AMERICA, INC. | $128.78 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $62.97 | 3 | $0 (2020) |
| Allergan Inc. | $39.10 | 3 | $0 (2017) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Merz Pharmaceuticals, LLC | $14.60 | 1 | $0 (2021) |
| Apyx Medical Corporation | $12.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55.07 | 1 | MERZ NORTH AMERICA, INC. ($55.07) |
| 2021 | $154.59 | 4 | Horizon Therapeutics plc ($139.99) |
| 2020 | $8,048 | 12 | Horizon Therapeutics plc ($8,006) |
| 2019 | $36.43 | 2 | Merz North America, Inc. ($36.43) |
| 2018 | $3,825 | 7 | Horizon Pharma plc ($3,796) |
| 2017 | $100.99 | 6 | Galderma Laboratories, L.P. ($40.50) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $55.07 | General |
| Category: Dermatology | ||||||
| 10/12/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Education | In-kind items and services | $8.22 | General |
| Category: TEPEZZA | ||||||
| 10/12/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Education | In-kind items and services | $8.22 | General |
| Category: TEPEZZA | ||||||
| 06/08/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $123.55 | General |
| Category: TEPEZZA | ||||||
| 04/29/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Musculoskeletal | ||||||
| 04/03/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 03/30/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $200.00 | General |
| Category: TEPEZZA | ||||||
| 03/10/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: TEPEZZA | ||||||
| 02/22/2020 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.37 | General |
| 02/20/2020 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.10 | General |
| 02/01/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $6,860.00 | General |
| Category: TEPEZZA | ||||||
| 02/01/2020 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $69.72 | General |
| 02/01/2020 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $65.49 | General |
| 02/01/2020 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $36.76 | General |
| 01/31/2020 | Horizon Therapeutics plc | — | Travel and Lodging | Cash or cash equivalent | $417.46 | General |
| 01/31/2020 | Horizon Therapeutics plc | — | Travel and Lodging | Cash or cash equivalent | $292.67 | General |
| 01/31/2020 | Horizon Therapeutics plc | — | Consulting Fee | Cash or cash equivalent | $45.00 | General |
| 06/07/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: DERMATOLOGY | ||||||
| 01/25/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2018 | Apyx Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $12.99 | General |
| 10/27/2018 | Horizon Pharma plc | TEPRO (Drug) | Travel and Lodging | Cash or cash equivalent | $433.21 | General |
| Category: TEPRO | ||||||
| 10/27/2018 | Horizon Pharma plc | TEPRO (Drug) | Travel and Lodging | In-kind items and services | $225.00 | General |
| Category: TEPRO | ||||||
| 10/27/2018 | Horizon Pharma plc | TEPRO (Drug) | Food and Beverage | In-kind items and services | $103.12 | General |
| Category: TEPRO | ||||||
| 10/27/2018 | Horizon Pharma plc | TEPRO (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: TEPRO | ||||||
| 10/10/2018 | Horizon Pharma plc | TEPRO (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: TEPRO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 118 | 2,208 | $22,466 | $13,930 |
| 2022 | 9 | 274 | 5,018 | $75,183 | $47,233 |
| 2021 | 15 | 464 | 6,832 | $136,780 | $85,896 |
| 2020 | 13 | 510 | 6,236 | $221,307 | $99,021 |
Total Patients
1,366
Total Services
20,294
Medicare Billing
$246,079
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 16 | 2,091 | $12,611 | $8,268 | 65.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 17 | 30 | $4,753 | $2,548 | 53.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 25 | 25 | $3,599 | $2,140 | 59.4% |
| 92285 | Photography of content of eyes | Office | 2023 | 40 | 42 | $910.56 | $594.65 | 65.3% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 20 | 20 | $592.05 | $380.12 | 64.2% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 21 | 4,704 | $28,224 | $18,435 | 65.3% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2022 | 19 | 19 | $16,568 | $7,772 | 46.9% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 21 | 63 | $10,684 | $6,755 | 63.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 62 | 62 | $8,962 | $6,531 | 72.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 24 | 29 | $3,531 | $2,631 | 74.5% |
| 67810 | Biopsy of eyelid | Office | 2022 | 14 | 15 | $2,565 | $1,838 | 71.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 21 | 27 | $2,315 | $1,580 | 68.2% |
| 92285 | Photography of content of eyes | Office | 2022 | 81 | 88 | $1,972 | $1,443 | 73.1% |
| 92081 | Exam of visual field with limited testing | Office | 2022 | 11 | 11 | $361.32 | $248.49 | 68.8% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2021 | 22 | 4,455 | $27,184 | $17,995 | 66.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 109 | 109 | $15,843 | $11,920 | 75.2% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2021 | 19 | 19 | $17,551 | $11,342 | 64.6% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Office | 2021 | 25 | 71 | $12,718 | $9,013 | 70.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 13 | 1,855 | $12,514 | $8,736 | 69.8% |
| 67903 | Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | Facility | 2021 | 11 | 11 | $10,115 | $5,237 | 51.8% |
| 67900 | Repair of brow paralysis | Facility | 2021 | 13 | 13 | $9,598 | $4,352 | 45.3% |
| 67916 | Repair of turning-outward eyelid defect | Facility | 2021 | 14 | 16 | $10,179 | $4,001 | 39.3% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2021 | 11 | 11 | $7,310 | $2,982 | 40.8% |
| 92285 | Photography of content of eyes | Office | 2021 | 138 | 158 | $3,651 | $2,660 | 72.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 27 | 30 | $3,697 | $2,656 | 71.8% |
About John Mccann, MD PHD
John Mccann, MD PHD is a Ophthalmology healthcare provider based in Columbia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326006917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Mccann, MD PHD has received a total of $12,220 in payments from pharmaceutical and medical device companies, with $55.07 received in 2024. These payments were reported across 32 transactions from 8 companies. The most common payment nature is "Honoraria" ($10,060).
As a Medicare-enrolled provider, Mccann has provided services to 1,366 Medicare beneficiaries, totaling 20,294 services with total Medicare billing of $246,079. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Plastic and Reconstructive Surgery, Plastic and Reconstructive Surgery
- Location Columbia, MO
- Active Since 05/03/2006
- Last Updated 04/12/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1326006917
Products in Payments
- TEPEZZA (Drug) $7,219
- TEPRO (Drug) $3,796
- Xeomin (Biological) $80.17
- XEOMIN (Biological) $52.32
- None Specified (Medical Supply) $19.40
- BOTOX NEURO REHAB (Drug) $16.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Columbia
Dr. Matthew Clary, M.d, M.D
Ophthalmology — Payments: $106,296
Ophthalmology $106,296
Dr. Jella An, M.d, M.D
Ophthalmology — Payments: $105,959
Ophthalmology $105,959
Dr. Rakesh Patel, M.d, M.D
Ophthalmology — Payments: $102,997
Ophthalmology $102,997
Sandra Johnson, M.d, M.D
Ophthalmology — Payments: $24,249
Ophthalmology $24,249
Willard Harms, Md, MD
Ophthalmology — Payments: $23,434
Ophthalmology $23,434
Frederick Fraunfelder, M.d, M.D
Ophthalmology — Payments: $12,972
Ophthalmology $12,972